False Advertising Under the Lanham Act: Literal Falsity, Materiality, and Competitor Standing

Summary. The federal claim against a competitor who lies about its product — or yours.

A trademark statute that is not about trademarks

Most people who know the Lanham Act know it as trademark law. But 15 U.S.C. § 1125(a) contains two distinct prohibitions, and the second one has nothing to do with source identification.

Section 43(a)(1)(A) covers false designation of origin — the passing-off and false endorsement provision that functions as federal unfair competition law.

Section 43(a)(1)(B) is the false advertising provision. It reaches any person who, in commercial advertising or promotion,

"misrepresents the nature, characteristics, qualities, or geographic origin of his or her or another person's goods, services, or commercial activities."

That is a remarkably broad sentence, and it creates something American law otherwise lacks: a private federal remedy for commercial lying. Consumer protection statutes are enforced by agencies and by consumers. The Federal Trade Commission Act, 15 U.S.C. § 45, has no private right of action at all. Section 43(a)(1)(B) fills that gap by letting the person with the strongest incentive to police an advertisement — the competitor being harmed by it — bring the case.

The practical result is a body of law shaped by competitor-versus-competitor litigation, with remedies calibrated to commercial injury rather than consumer redress.

The elements

Courts articulate the elements slightly differently by circuit, but a working formulation requires the plaintiff to prove:

1. A false or misleading statement of fact in a commercial advertisement;
2. That actually deceived or has the tendency to deceive a substantial segment of the audience;
3. That the deception is material, likely to influence a purchasing decision;
4. That the defendant caused the statement to enter interstate commerce; and
5. That the plaintiff has been or is likely to be injured as a result.

Elements one and three carry the analysis. Element two collapses into element one when the statement is literally false, for reasons explained below.

Literal falsity versus implied falsity

This is the central distinction in the field, and it determines how expensive the case will be.

Literal falsity

A statement is literally false if, on its face, it is untrue. "Our detergent removes 99% of stains" is literally false if it removes 60%. "Clinically proven to reduce recovery time by half" is literally false if no clinical study exists.

The consequence is procedural and enormous: where a statement is literally false, courts presume consumer deception. The plaintiff does not need a survey. It does not need to prove that anyone was actually misled. It proves the statement, proves the falsity, and the deception element is satisfied.

This is why the first question in every false advertising case is whether the challenged statement can be characterized as literally false.

Two refinements matter:

Falsity by necessary implication. A statement can be literally false even if not explicitly untrue, where the audience would unavoidably receive the false message. If an advertisement says "the only product with ingredient X" and a competitor's product also contains X, the claim is false by necessary implication even though the words are technically about the advertiser's own product. Courts require that the implication be unavoidable, not merely likely.

Establishment claims. A claim that a proposition is "clinically proven," "scientifically demonstrated," or "tested to show" is an establishment claim, and it carries a distinctive burden. The plaintiff need not prove the underlying proposition is false. It need only prove that the studies relied on do not establish it — because they were not sufficiently reliable, not conducted on the product at issue, not designed to test the claim, or misrepresented in the advertisement. This is a materially easier showing than disproving the substantive claim, and it is the single most effective attack available against science-based advertising.

Implied falsity

A statement that is literally true may still be misleading in context. "Made with real fruit" on a product containing 2% fruit juice is not literally false, but it may convey a message that the product is substantially fruit.

The consequence is procedural and expensive: for an implied falsity theory, the plaintiff must prove what message consumers actually received, which in practice means consumer survey evidence.

Survey work in false advertising is a discipline of its own:

• The universe must be the relevant purchasing population, not the general public.
• The stimulus must be the actual advertisement, not a description of it.
• A control is required to separate the effect of the challenged element from background noise.
• Questions must be non-leading, and the sequence must not suggest the answer.
• The threshold at which courts find a substantial segment deceived is not fixed, but figures in the range of 15–20% net deception are commonly treated as sufficient, and lower figures are commonly treated as insufficient.

Surveys are attacked under Federal Rule of Evidence 702, and a survey with a defective universe or no control is frequently excluded, which ends the implied falsity case.

Puffery

Not every exaggeration is actionable. Puffery — subjective claims of superiority that no reasonable consumer would take as a factual representation — is outside the statute.

"The best pizza in town." "Unbeatable value." "Simply the finest." These are not statements of fact capable of being proven true or false.

The line is drawn by specificity and measurability:

The right-hand column shares a feature: each contains something a person could go measure.

A recurring trap for advertisers is that a puffing claim placed next to a specific claim can lose its protection, because the context supplies the factual grounding the puff lacked. "Simply the best — 40% more effective" is one message, not two.

Materiality

Falsity is not enough. The misrepresentation must be material — likely to influence a purchasing decision.

Where a statement is literally false about an inherent quality or characteristic of the product, courts often presume materiality. Where the statement concerns a peripheral matter, the plaintiff must prove it mattered.

Evidence of materiality includes: the advertiser's own consumer research showing the claim drives purchase; the prominence of the claim in the campaign and the money spent on it; survey evidence testing purchase intent; and testimony from purchasers.

The advertiser's own documents are the best source. A company that spent $12 million promoting a claim because its research showed the claim drove conversion has proved the plaintiff's materiality case in its own files. This is the single highest-value discovery target in false advertising litigation.

Who may sue

For decades, circuits used incompatible tests — some requiring actual competition, some using a multifactor prudential standing analysis, some barring consumers categorically.

Lexmark International, Inc. v. Static Control Components, Inc., 572 U.S. 118 (2014) replaced all of it with a unanimous, straightforward framework. The question is not "prudential standing" but simply whether the plaintiff has a cause of action under the statute, answered by two familiar tools:

The zone of interests. The plaintiff must allege an injury to a commercial interest in reputation or sales. The Court was explicit that this excludes consumers:

"[A] consumer who is hoodwinked into purchasing a disappointing product may well have an injury-in-fact cognizable under Article III, but he cannot invoke the protection of the Lanham Act."

Proximate causation. The plaintiff must show economic or reputational injury flowing directly from the deception, which "occurs when deception of consumers causes them to withhold trade from the plaintiff."

What Lexmark changed in practice:

• Direct competition is not required. Static Control made components for cartridges; it did not compete with Lexmark in the cartridge market. It had a claim.
• Consumers cannot sue under the Lanham Act. Their remedies are state consumer protection statutes.
• The analysis is unified nationally, ending decades of circuit conflict.
• Remote parties still lose. A supplier several steps removed, or a plaintiff whose injury is derivative of harm to someone else, fails proximate cause.

The regulatory overlay

Advertising is regulated by agencies as well as by competitors, and the interaction produces some of the field's hardest questions.

POM Wonderful LLC v. Coca-Cola Co., 573 U.S. 102 (2014) addressed whether the Food, Drug, and Cosmetic Act's labeling regime precluded a Lanham Act claim about a juice label. The Court held it did not:

"The Lanham Act and the FDCA complement each other in the federal regulation of misleading food and beverage labels. Competitors, in their own interest, may bring Lanham Act claims like POM's that challenge food and beverage labels that are regulated by the FDCA."

The reasoning turned on the different purposes and enforcers of the two statutes: the FDCA is enforced by the government to protect public health; the Lanham Act is enforced by competitors to protect commercial interests. Compliance with one does not immunize against the other.

But there are limits. Where a claim would require a court to determine whether the defendant violated a regulatory requirement that the agency has exclusive authority to interpret, courts frequently find the claim precluded — the "you cannot use the Lanham Act to privately enforce the FDCA" principle. The distinction is between challenging a statement as false (permitted) and challenging conduct as non-compliant (often not).

Similar analyses arise with drug labeling, pesticide registration, and other approval regimes, and the outcomes are fact-specific.

Remedies

Injunctive relief

Usually the objective. Under 15 U.S.C. § 1116, courts may grant injunctions according to principles of equity.

A preliminary injunction requires the four-factor showing of Winter v. Natural Resources Defense Council, Inc., 555 U.S. 7 (2008): likelihood of success, irreparable harm, balance of equities, and the public interest, under Federal Rule of Civil Procedure 65.

Irreparable harm is now presumed on a finding of a violation. Congress amended the Lanham Act in 2020 to restore a rebuttable presumption of irreparable harm upon a finding of a violation, or upon a finding of likelihood of success at the preliminary stage. This reversed a line of cases applying eBay to eliminate the presumption, and it materially improved plaintiffs' position.

Speed matters. Advertising campaigns are finite. A plaintiff that takes six months to move for a preliminary injunction faces two problems: the campaign may be over, and the delay itself undercuts the irreparable harm showing.

Money

15 U.S.C. § 1117 provides for the defendant's profits, the plaintiff's damages, and costs, subject to principles of equity.

Profits. Romag Fasteners, Inc. v. Fossil, Inc., 590 U.S. 212 (2020) held that willfulness is not a precondition to a profits award under § 1117(a) — resolving a long circuit split. Willfulness remains highly relevant to the equitable determination, but it is not a threshold. The burden structure is favorable: the plaintiff proves the defendant's sales; the defendant must prove all elements of cost or deduction.

Damages. Lost sales, price erosion, and harm to goodwill. Proof is difficult because causation must connect the advertisement to specific lost business, and defendants argue that many factors drive purchasing.

Corrective advertising. Courts may award the cost of advertising to repair the damage, either prospectively or by reference to what the plaintiff actually spent. Some courts use a fraction of the defendant's advertising expenditure as a benchmark, though this approach draws criticism.

Enhancement. The court may enter judgment for up to three times actual damages according to the circumstances, and may adjust a profits award if it finds the amount inadequate or excessive.

Fees. Available in exceptional cases, using the standard borrowed from patent practice under Octane Fitness. Available to prevailing defendants as well.

Frequently asked questions

How long do I have to sue? The Lanham Act contains no statute of limitations for false advertising. Courts borrow the most analogous state limitations period and apply laches, which examines the length of the delay and the prejudice to the defendant. Practically, delay hurts long before any limitations period runs, because it undercuts irreparable harm.

Can I challenge an advertisement that does not name my company? Yes. Most actionable comparative advertising refers to "the leading brand" or "competing products" rather than naming anyone. What matters is whether the audience would understand the reference and whether the plaintiff is injured.

What if the false claim appears only on a product label? Labels are squarely within "commercial advertising or promotion," and POM Wonderful confirms that a parallel federal labeling regime does not preclude the claim.

Are there defenses unique to this claim? Beyond falsity, materiality, and standing: puffery; substantial truth; the statement was not commercial advertising or promotion; preclusion by a regulatory scheme; laches and acquiescence; and unclean hands where the plaintiff makes the same claim itself. That last one arises more often than one would expect and is worth checking before filing.

Can consumers bring a Lanham Act false advertising claim? No. Lexmark holds that consumer injury falls outside the statute's zone of interests. Consumers use state consumer protection statutes.

Do the parties have to compete directly? No. Lexmark replaced the direct-competition requirement with a zone-of-interests and proximate-cause analysis.

Is a survey always required? No — only for implied falsity. A literally false statement carries a presumption of deception.

What is an establishment claim? An advertisement asserting that a proposition has been proven or tested. The challenger need only show the cited studies do not establish the claim, not that the claim is substantively false.

Does compliance with agency regulation protect an advertiser? Not automatically. POM Wonderful holds that the Lanham Act and the FDCA operate in parallel. But a claim that would require a court to enforce a regulatory requirement directly may be precluded.

Is comparative advertising lawful? Yes, and it is protected. It becomes actionable when the comparison is false or misleading, or when the substantiation does not support it.

Does a disclaimer cure a false claim? Rarely. A disclaimer that is inconspicuous, or that contradicts the main message, does not defeat a false advertising claim. Courts examine the overall impression.

What about advertising by a non-competitor, like a review site? The statute reaches "commercial advertising or promotion," which requires commercial speech by a party with an economic motivation, disseminated sufficiently to the relevant purchasing public. Editorial reviews and journalism generally fall outside it.

Three campaigns, three analyses

The performance claim

Kestrel Thermal advertises its insulated shipping container as "keeping contents below 8°C for 96 hours — 40% longer than the leading competitor." The leading competitor is Bordeaux Cold Chain, whose container holds temperature for 82 hours in Kestrel's own testing.

Analysis. 96 versus 82 is a 17% difference, not 40%. The claim is literally false on the arithmetic, and deception is presumed.

But the fight will be about the test protocol. Kestrel will argue it tested at a different ambient temperature, with a different payload mass, or against a different competitor model. This is where false advertising cases actually live: not in whether the number is right but in whether the test that produced it measured what the advertisement claims.

Bordeaux's strongest move is to reframe the claim as an establishment claim. "40% longer" implies testing. Bordeaux need not prove its own container performs better; it need only prove that Kestrel's testing does not establish the 40% figure — wrong protocol, non-representative sample, uncontrolled variables, or a comparison against a discontinued model. That is a much easier case, and it is the reason technical claims should never be published without a substantiation file that would survive a hostile expert.

Materiality is straightforward: hold time is the reason customers buy these containers, and Kestrel's own marketing research will say so.

The ingredient claim

Sorrel & Vane sells a skincare line advertised as "Formulated Without Parabens, Sulfates, or Synthetic Fragrance." Every statement is true. The packaging also carries a botanical illustration, the phrase "Clean Beauty," and a back-panel note that the product is "inspired by nature."

Competitor Ilkeston Naturals alleges the overall impression conveys that the products are natural or plant-derived, when they are approximately 70% synthetic.

Analysis. Nothing here is literally false. This is an implied falsity case, and it therefore requires a survey.

Ilkeston must design a study showing that a substantial segment of the relevant purchasing population takes away the message "these products are primarily natural." The survey needs a proper universe (purchasers of premium skincare), the actual packaging as stimulus, a control cell removing the challenged elements, non-leading questions, and a net deception figure high enough to matter.

Sorrel & Vane's defenses are strong: "Clean Beauty" is an undefined marketing term arguably amounting to puffery; the negative claims are true; and the botanical illustration is decorative. It will also attack the survey under Federal Rule of Evidence 702 — the most common and most effective response to an implied falsity case.

Practical reality: implied falsity cases cost several hundred thousand dollars before anyone reaches the merits, because two surveys and two survey experts are required. Many resolve at the National Advertising Division instead, where the process is faster and cheaper.

The regulatory claim

Halberd Diagnostics markets a rapid test kit as "FDA Cleared." The device was the subject of a 510(k) submission, but clearance has not issued.

Competitor Ostrander Labs sues under 15 U.S.C. § 1125(a).

Analysis. This is literally false and does not require a court to interpret any regulation — the statement "FDA Cleared" is either true or not, and the agency's records answer it. Under POM Wonderful LLC v. Coca-Cola Co., 573 U.S. 102 (2014), the existence of the regulatory scheme does not preclude the claim.

Contrast a claim that would be precluded. If Ostrander instead alleged that Halberd's cleared device was being promoted for an off-label use in violation of agency requirements, a court would be asked to determine regulatory compliance — a determination the agency has authority to make. Many courts would find that claim precluded.

The line: challenging a statement as false is permitted. Asking a court to enforce a regulatory scheme usually is not.

Building the case

For the plaintiff

Capture everything, immediately. Advertisements change. Screenshot web pages with visible URLs and dates, record broadcast spots, retain print, and preserve packaging by purchasing the product. Archive services help but do not substitute for contemporaneous capture.

Characterize the claim as literally false if you honestly can. The presumption of deception is the difference between a manageable case and a survey-driven one. Look hard at:

• Arithmetic and measurable assertions
• Establishment language ("proven," "tested," "clinically shown")
• Necessary implications that are genuinely unavoidable
• Claims of exclusivity ("only," "first," "patented")

If the theory is implied falsity, budget for a survey from day one. Retain the expert before filing so the survey can be designed properly rather than assembled under a scheduling order.

Move fast on preliminary relief. Campaigns end. Delay undermines irreparable harm even with the statutory presumption. A plaintiff that discovers a campaign in March and moves in October will be asked why.

Target the defendant's own files. The highest-value discovery in these cases:

• Substantiation files for the challenged claim
• Testing protocols, raw data, and any tests that did not support the claim
• Consumer research on message takeaway and purchase drivers
• Marketing plans showing spend behind the claim
• Legal and regulatory review of the campaign, subject to privilege fights
• Communications with the agency or research vendor
• Sales data before and after the campaign

Prove your own injury. Lost sales, lost accounts, price concessions, and customer statements. Proximate cause under Lexmark International, Inc. v. Static Control Components, Inc., 572 U.S. 118 (2014) requires connecting the deception to withheld trade.

For the defendant

Attack the falsity characterization first. Is the statement literally false, or is the plaintiff describing an implied message? Forcing the case into implied falsity forces a survey and multiplies the plaintiff's burden and cost.

Test the survey ruthlessly. Universe, stimulus, control, question wording, order effects, and net deception calculation. Survey exclusion ends most implied falsity cases.

Raise puffery where it fits — but do not overreach. A puffery argument advanced against a measurable claim damages credibility on the arguments that matter.

Examine materiality. Even a false statement is not actionable if it did not influence purchasing. Peripheral claims, fine print, and statements in low-circulation channels are candidates.

Examine standing. Is the plaintiff within the zone of interests? Is the injury proximately caused, or derivative of harm to someone else?

Consider a counterclaim. Advertising disputes are frequently mutual, and a counterclaim changes settlement dynamics substantially.

Build the substantiation record before the campaign runs. The best defense is a file assembled in advance showing that the claim was tested competently, that the protocol matches the claim, and that the advertisement accurately describes the result. Substantiation created after a complaint arrives is worth much less.

The alternatives to litigation

Most advertising disputes never reach a courthouse, and counsel who reach for a complaint first are frequently choosing the slowest and most expensive option.

The National Advertising Division

The advertising industry's self-regulatory forum reviews national advertising claims on a documentary record.

• Speed. Decisions typically issue within a few months.
• Cost. A fraction of litigation, with a modest filing fee.
• Process. No discovery, no depositions, no live testimony. Written submissions and a substantiation review.
• Remedy. A recommendation to modify or discontinue the claim. Compliance is voluntary.
• Compliance is high — participants generally comply, because non-compliance is referred to the Federal Trade Commission and the referral is published.
• Appeal. To the National Advertising Review Board.

When it is the right forum: claims that turn on substantiation adequacy; disputes where the objective is stopping the claim rather than recovering money; and situations where the parties have an ongoing commercial relationship worth preserving. It is particularly well suited to establishment-claim disputes, because reviewing whether studies support a claim is exactly what the process does.

When it is not: where damages matter; where the advertiser is unlikely to participate or comply; where speed of days rather than months is required; and where the dispute involves conduct beyond advertising claims.

Regulatory referral

The Federal Trade Commission enforces 15 U.S.C. § 45 against deceptive practices and has authority the private plaintiff lacks — including relief for consumers and industry-wide rulemaking. It has no private right of action, so a competitor's role is to complain rather than to sue. State attorneys general have parallel authority under state statutes and are frequently more responsive to a well-documented complaint from an in-state business.

The limitations: the agency chooses its own cases, the timeline is unpredictable, and the complainant has no control over the outcome or standing to appeal.

Platform and media channels

Advertising runs somewhere, and the somewhere has rules.

• Broadcast networks review claims before airing, and a substantiation challenge to the network's clearance department can pull a spot faster than any court.
• Retail platforms and marketplaces have listing accuracy policies and remove non-compliant claims on documented complaint.
• Search and social advertising platforms prohibit misleading claims and enforce through account-level policies.
• Industry certification bodies can withdraw marks and seals used in the challenged advertising.

These channels are fast, cheap, and frequently sufficient. They are also uncoordinated, so a serious campaign against a false claim may involve four or five simultaneous approaches.

The demand letter

Still the most common resolution. An effective one identifies the specific claim, states precisely why it is false, attaches the evidence, and asks for a substantiation response by a date. It does not threaten remedies that are unavailable, and it does not characterize a close call as a clear violation — because the letter will be attached to the declaratory judgment complaint if the recipient decides to fight.

What counts as "commercial advertising or promotion"

The statute does not reach every false commercial statement. It reaches misrepresentations "in commercial advertising or promotion," and courts apply a test with recognizable components: the speech must be commercial speech, made by a party in commercial competition with the plaintiff or otherwise within the zone of interests after Lexmark, for the purpose of influencing consumers to buy, and disseminated sufficiently to the relevant purchasing public.

Each element does work.

Commercial speech. Editorial content, journalism, reviews, and academic writing are outside the statute even when they harm a business. The remedy there, if any, is defamation or trade libel, with their much higher burdens.

Dissemination. A single statement to one customer is usually not "promotion." But in a market with five buyers, statements to two of them may be — courts scale the requirement to the size of the relevant market. This matters enormously in business-to-business industries, where a false statement made in three sales presentations can reach most of the addressable market.

Purpose. Statements made in litigation, in regulatory filings, and in response to due diligence inquiries are generally not promotional, though a "white paper" circulated to prospects is.

Recurring gray areas:

• Sales presentations and RFP responses. Frequently actionable in concentrated markets.
• Press releases. Actionable where they promote products; not where they report corporate events.
• Investor communications. Generally directed at investors rather than purchasers, and often outside the statute — though statements that reach customers may qualify.
• Social media by employees and influencers. Attributable to the company where directed or compensated; the endorsement guides at 16 C.F.R. Part 255 impose parallel obligations.
• Product packaging and labeling. Squarely within the statute, as POM Wonderful confirms.
• Comparative testing published by a trade group. Depends on whether the group is acting commercially or informationally.

Coordinating a claim with other theories

False advertising rarely travels alone. A well-pleaded complaint usually includes several of the following, and understanding what each adds prevents pleading a claim that only invites a motion.

Trademark infringement under 15 U.S.C. § 1114 and false designation under § 1125(a)(1)(A), where the advertising also misuses a mark.

Trade libel or product disparagement under state law, where the falsity concerns the plaintiff's product rather than the defendant's. Note the difference: § 43(a)(1)(B) reaches misrepresentations about "his or her or another person's goods," so disparagement of a competitor is covered by the federal statute too — but state claims may offer punitive damages the Lanham Act does not.

Tortious interference, where the false statements were directed at identified customers or contracts.

State unfair competition and consumer protection statutes, many of which permit business plaintiffs and some of which offer treble damages or fee-shifting more generous than the Lanham Act's exceptional-case standard.

Breach of contract, where the parties had a coexistence, settlement, or distribution agreement addressing advertising claims.

Defamation, where statements concern the plaintiff's business integrity rather than its products. The constitutional overlay is heavier and the elements are harder.

A caution about pleading everything. Duplicative claims invite motions to dismiss and dilute the narrative. The strongest complaints plead the Lanham Act claim carefully, add one or two state claims that supply remedies the federal claim lacks, and stop.

Substantiation: the compliance side of the doctrine

Every rule described above has a mirror image on the advertiser's side, and the mirror image is a file.

The principle. An advertiser should possess, before the claim runs, evidence that reasonably supports it. This is the Federal Trade Commission's prior substantiation doctrine, and it is also, in practice, how false advertising litigation is decided — because the first document requested in every case is the substantiation file, and its adequacy usually determines the outcome.

What "reasonable basis" means depends on the claim.

• Express or implied establishment claims ("clinically proven," "tested to show") require the level of support the advertisement itself claims. If the advertisement says "two clinical studies show," there must be two clinical studies showing it.
• Health, safety, and efficacy claims generally require competent and reliable scientific evidence — testing conducted by qualified persons using procedures generally accepted in the field to yield accurate results.
• Performance and comparative claims require testing under conditions matching the claim, against the products actually named or reasonably identified.
• Subjective and taste claims may be supported by properly conducted preference testing.
• Puffery requires nothing, because it asserts nothing.

What belongs in the file:

Two rules that prevent most problems. First, the claim and the test must match — a claim about 96 hours at 8°C must rest on a test at that temperature for that duration with a representative payload. Second, do not run a claim the file will not support in a hostile deposition, because the substantiation file is not a compliance formality; it is the exhibit the case turns on.

Review cadence. Substantiation ages. Competitor products change, standards evolve, and a comparison valid in 2024 may be false in 2026 without anyone editing the advertisement. Advertisers running comparative claims should re-verify at defined intervals and calendar the review, because a claim that became false through the passage of time is still false.

A note on how these cases actually end

Reading the doctrine, one would expect false advertising disputes to be resolved by juries applying the five elements. Almost none are.

The preliminary injunction is the case. Because advertising campaigns are finite and the harm is ongoing, the practical contest happens in the first sixty to ninety days. A plaintiff that wins a preliminary injunction has usually won everything it wanted; a plaintiff that loses one usually settles or abandons. The 2020 amendment restoring the presumption of irreparable harm made this dynamic sharper, not weaker.

Most claims are modified rather than litigated. The overwhelming majority of challenges — through demand letters, network clearance departments, platform complaints, and the National Advertising Division — end with the advertiser adjusting a word, adding a footnote, or narrowing a comparison. That is usually the right outcome. A competitor who wanted the claim stopped got the claim stopped, in weeks, for a fraction of the cost.

Damages awards are rare and often modest. Proving that a specific advertisement caused specific lost sales is genuinely hard, and defendants have many alternative explanations. Profits awards under 15 U.S.C. § 1117 are more attainable after Romag Fasteners, Inc. v. Fossil, Inc., 590 U.S. 212 (2020) removed the willfulness precondition, but they require the court to exercise equitable discretion and courts remain cautious about awarding a defendant's entire profits for a single false claim in a multi-element campaign.

Fee awards discipline the field. Because fees are available to prevailing defendants under the exceptional-case standard, a marginal challenge brought for competitive harassment carries real risk. This is healthy: the statute is a tool for stopping lies, not for slowing a competitor down.

What this means for counsel. Decide early what you actually want. If the answer is "make the claim stop," the fastest route is usually not a complaint — it is a well-documented substantiation challenge sent to the advertiser, the network, or the self-regulatory forum, with litigation held in reserve. If the answer is "recover the business we lost," be honest with the client about how difficult that proof is before the retainer is signed.

Related documents

• Bringing or Defending a False Advertising Claim: A Practical Guide
• False Advertising Claim Checklist: A Practical Checklist
• False Advertising Toolkit: Substantiation Files, Surveys, and Injunction Briefing
• Advertising and Consumer Protection Compliance Toolkit
• Consumer Marketing Compliance Toolkit: TCPA, CAN-SPAM, Auto-Renewal, and Endorsements
• Tortious Interference and Unfair Competition Claims Between Businesses
• Defamation, Business Disparagement, and Online Reviews
• Preliminary Injunctions and Temporary Restraining Orders: Emergency Relief in Federal Court
• Consumer Survey Expert Methodology in Trademark Cases: A Practical Guide